Calpain Activity Is Generally Elevated during Transformation but Has Oncogene-Specific Biological Functions

Neoplasia

Volumn 6, Issue 1, 2004, Pages 53-73

  Carragher, Neil O ^a,c   Fonseca, B D ^a   Frame, M C ^a,b  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Garscube Estate   (United Kingdom)

Author keywords

Apoptosis; Calpain; Focal adhesion; Migration; Oncogene

Indexed keywords

ACTIN; CALPAIN; FOCAL ADHESION KINASE; K RAS PROTEIN; MYC PROTEIN; ONCOPROTEIN; PROTEIN V FOS; PROTEIN V JUN; PROTEIN V SRC; SPECTRIN; TALIN; UNCLASSIFIED DRUG; V MYC PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CELL MIGRATION; CELL STRUCTURE; CELL TRANSFORMATION; CHICK EMBRYO; CONTROLLED STUDY; CYTOSKELETON; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; FOCAL ADHESION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTO ONCOGENE;

EID: 1642349839     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1476-5586(04)80053-8     Document Type: Article

References (84)

1. Emori Y, Kawasaki H, Imajoh S, Imahori K, and Suzuki K (1987). Endogenous inhibitor for calcium-dependent cysteine protease contains four internal repeats that could be responsible for its multiple reactive sites. Proc Natl Acad Sci USA 84, 3590-3594.
2. Maki M, Bagci H, Hamaguchi K, Ueda M, Murachi T, and Hatanaka M (1989). Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. J Biol Chem 264, 18866-18869.
3. Kawasaki H, Emori Y, Imajoh-Ohmi S, Minami Y, and Suzuki K (1989). Identification and characterization of inhibitory sequences in four repeating domains of the endogenous inhibitor for calcium-dependent protease. J Biochem (Tokyo) 106, 274-281.
4. Carragher NO, Fincham VJ, Riley D, and Frame MC (2001). Cleavage of focal adhesion kinase by different proteases during SRC-regulated transformation and apoptosis. Distinct roles for calpain and caspases. J Biol Chem 276, 4270-4275.
5. Huttenlocher A, Palecek SP, Lu Q, Zhang W, Mellgren RL, Lauffenburger DA, Ginsberg MH, and Horwitz AF (1997). Regulation of cell migration by the calcium-dependent protease calpain. J Biol Chem 272, 32719-32722.
6. Murray SS, Grisanti MS, Bentley GV, Kahn AJ, Urist MR, and Murray EJ (1997). The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells. Exp Cell Res 233, 297-309.
7. Nakagawa T and Yuan J (2000). Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150, 887-894.
8. Patel YM and Lane MD (2000). Mitotic clonal expansion during pre-adipocyte differentiation: calpain-mediated turnover of p27. J Biol Chem 275, 17653-17660.
9. Sorimachi H, Ishiura S, and Suzuki K (1997). Structure and physiological function of calpains. Biochem J 328, 721-732.
10. Beckerle MC, Burridge K, DeMartino GN, and Croall DE (1987). Colocalization of calcium-dependent protease II and one of its substrates at sites of cell adhesion. Cell 51, 569-577.
11. Bialkowska K, Kulkarni S, Du X, Goll DE, Saido TC, and Fox JE (2000). Evidence that beta3 integrin-induced Rac activation involves the calpain-dependent formation of integrin clusters that are distinct from the focal complexes and focal adhesions that form as Rac and RhoA become active. J Cell Biol 151, 685-696.
12. Dourdin N, Bhatt AK, Dutt P, Greer PA, Arthur JS, Elce JS, and Huttenlocher A (2001). Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J Biol Chem 276, 48382-48388.
13. Bhatt A, Kaverina I, Otey C, and Huttenlocher A (2002). Regulation of focal complex composition and disassembly by the calcium-dependent protease calpain. J Cell Sci 115, 3415-3425.
14. Huang C, Tandon NN, Greco NJ, Ni Y, Wang T, and Zhan X (1997). Proteolysis of platelet cortactin by calpain. J Biol Chem 272, 19248-19252.
15. Hu RJ and Bennett V (1991). In vitro proteolysis of brain spectrin by calpain I inhibits association of spectrin with ankyrin-independent membrane binding site(s). J Biol Chem 266, 18200-18205.
16. Potter DA, Tirnauer JS, Janssen R, Croall DE, Hughes CN, Fiacco KA, Mier JW, Maki M, and Herman IM (1998). Calpain regulates actin remodeling during cell spreading. J Cell Biol 141, 647-662.
17. Kulkarni S, Goll DE, and Fox JE (2002). Calpain cleaves RhoA generating a dominant-negative form that inhibits integrin-induced actin filament assembly and cell spreading. J Biol Chem 277, 24435-24441.
18. 2+-dependent thiol protease. Eur J Biochem 155, 409-413.
19. Hirai S, Kawasaki H, Yaniv M, and Suzuki K (1991). Degradation of transcription factors, c-Jun and c-Fos, by calpain. FEBS Lett 287, 57-61.
20. Carillo S, Pariat M, Steff AM, Roux P, Etienne-Julan M, Lorca T, and Piechaczyk M (1994). Differential sensitivity of FOS and JUN family members to calpains. Oncogene 9, 1679-1689.
21. Oda A, Druker BJ, Ariyoshi H, Smith M, and Salzman EW (1993). pp60src is an endogenous substrate for calpain in human blood platelets. J Biol Chem 268, 12603-12608.
22. Watanabe N, Vande Woude GF, Ikawa Y, and Sagata N (1989). Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs. Nature 342, 505-511.
23. Gregoriou M, Willis AC, Pearson MA, and Crawford C (1994). The calpain cleavage sites in the epidermal growth factor receptor kinase domain. Eur J Biochem 223, 455-464.
24. Hiwasa T, Nakata M, Ohno S, Maki M, Suzuki K, and Takiguchi M (2002). Regulation of transformed state by calpastatin via PKCepsilon in NIH3T3 mouse fibroblasts. Biochem Biophys Res Commun 290, 510-517.
25. Liu K, Li L, and Cohen SN (2000). Antisense RNA-mediated deficiency of the calpain protease, nCL-4, in NIH3T3 cells is associated with neoplastic transformation and tumorigenesis. J Biol Chem 275, 31093-31098.
26. Kubbutat MH and Vousden KH (1997). Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol 17, 460-468.
27. Kimura Y, Saya H, and Nakao M (2000). Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas. Neuropathology 20, 153-160.
28. Miyamoto S, Seufzer BJ, and Shumway SD (1998). Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells. Mol Cell Biol 18, 19-29.
29. Jang JS, Lee SJ, Choi YH, Nguyen PM, Lee J, Hwang SG, Wu ML, Takano E, Maki M, and Henkart PA (1999). Posttranslational regulation of the retinoblastoma gene family member p107 by calpain protease. Oncogene 18, 1789-1796.
30. Carragher NO, Westhoff MA, Riley D, Potter DA, Dutt P, Elce JS, Greer PA, Frame MC (2002). v-Src-induced modulation of the calpain-calpastatin proteolytic system regulates transformation. Mol Cell Biol 22, 257-269.
31. Carragher NO and Frame MC (2002). Calpain: a role in cell transformation and migration. Int J Biochem Cell Biol 34, 1539-1543.
32. Postovit LM, Dutt P, Dourdin N, Park M, Greer PA, Graham CH, and Elce JS (2002). Calpain is required for MMP-2 and u-PA expression in SV40 large T-antigen-immortalized cells. Biochem Biophys Res Commun 297, 294-301.
33. Glading A, Chang P, Lauffenburger DA, and Wells A (2000). Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem 275, 2390-2398.
34. Romieu-Mourez R, Landesman-Bollag E, Seldin DC, and Sonenshein GE (2002). Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Res 62, 6770-6778.
35. Mamoune A, Luo JH, Lauffenburger DA, and Wells A (2003). Calpain-2 as a target for limiting prostate cancer invasion. Cancer Res 63, 4632-4640.
36. Braun C, Engel M, Seifert M, Theisinger B, Seitz G, Zang KD, and Welter C (1999). Expression of calpain I messenger RNA in human renal cell carcinoma: correlation with lymph node metastasis and histological type. Int J Cancer 84, 6-9.
37. 2+-dependent neutral protease (calpain) activity in breast cancer tissue and estrogen receptor status. Breast Cancer 3, 13-17.
38. Wang XD, Rosales JL, Magliocco A, Gnanakumar R, and Lee KY (2003). Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain. Oncogene 22, 769-774.
39. Witkowski JM, Zmuda-Trzebiatowska E, Swiercz JM, Cichorek M, Ciepluch H, Lewandowski K, Bryl E, and Hellmann A (2002). Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood 100, 1802-1809.
40. Yoshikawa Y, Mukai H, Hino F, Asada K, and Kato I (2000). Isolation of two novel genes, down-regulated in gastric cancer. Jpn J Cancer Res 91, 459-463.
41. Fincham VJ, Wyke JA, and Frame MC (1995). v-Src-induced degradation of focal adhesion kinase during morphological transformation of chicken embryo fibroblasts. Oncogene 10, 2247-2252 (published erratum appears in Oncogene 1995; 11(10), 2185).
42. Fincham VJ, Wyke JA, and Frame MC (1995). v-Src-induced degradation of focal adhesion kinase during morphological transformation of chicken embryo fibroblasts. Oncogene 10, 2247-2252 (published erratum appears in Oncogene 1995; 11(10), 2185).
43. Welham MJ and Wyke JA (1988). A single point mutation has pleiotropic effects on pp60v-src function. J Virol 62, 1898-1906.
44. Gardner AM, Vaillancourt RR, and Johnson GL (1993). Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase by G protein and tyrosine kinase oncoproteins. J Biol Chem 268, 17896-17901.
45. Giehl K, Skripczynski B, Mansard A, Menke A, and Gierschik P (2000). Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration. Oncogene 19, 2930-2942.
46. Glading A, Uberall F, Keyse SM, Lauffenburger DA, and Wells A (2001). Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem 276, 23341-23348.
47. Sasaki T, Kishi M, Saito M, Tanaka T, Higuchi N, Kominami E, Katunuma N, and Murachi T (1990). Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins. J Enzyme Inhib 3, 195-201.
48. + donors by cysteine protease inhibitors. J Immunol 153, 862-872.
49. Squier MK, Miller AC, Malkinson AM, and Cohen JJ (1994). Calpain activation in apoptosis. J Cell Physiol 159, 229-237.
50. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, and Schreiber SL (1995). Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268, 726-731.
51. Seglen PO, Grinde B, and Solheim AE (1979). Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin. Eur J Biochem 95, 215-225.
52. Ziegler HK and Unanue ER (1982). Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci USA 79, 175-178.
53. Sever N, Filipic M, Brzin J, and Lah TT (2002). Effect of cysteine proteinase inhibitors on murine B16 melanoma cell invasion in vitro. Biol Chem 383, 839-842.
54. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, and Yamamoto T (1995). Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539-544.
55. Burridge K and Connell L (1983). Talin: a cytoskeletal component concentrated in adhesion plaques and other sites of actin-membrane interaction. Cell Motil 3, 405-417.
56. Parsons JT (2003). Focal adhesion kinase: the first ten years. J Cell Sci 116, 1409-1416.
57. Bennett V and Gilligan DM (1993). The spectrin-based membrane skeleton and micron-scale organization of the plasma membrane. Annu Rev Cell Biol 9, 27-66.
58. Cooray P, Yuan Y, Schoenwaelder SM, Mitchell CA, Salem HH, and Jackson SP (1996). Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain. Biochem J 318, 41-47.
59. Carragher NO, Levkau B, Ross R, and Raines EW (1999). Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin. J Cell Biol 147, 619-630.
60. Hayashi M, Suzuki H, Kawashima S, Saido TC, and Inomata M (1999). The behavior of calpain-generated N- and C-terminal fragments of talin in integrin-mediated signaling pathways. Arch Biochem Biophys 371, 133-141.
61. Nath R, Raser KJ, Stafford D, Hajimohammadreza I, Posner A, Allen H, Talanian RV, Yuen P, Gilbertsen RB, and Wang KK (1996). Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem J 319, 683-690.
62. Wen LP, Fahrni JA, Troie S, Guan JL, Orth K, and Rosen GD (1997). Cleavage of focal adhesion kinase by caspases during apoptosis. J Biol Chem 272, 26056-26061.
63. Levkau B, Herren B, Koyama H, Ross R, and Raines EW (1998). Caspase-mediated cleavage of focal adhesion kinase pp125FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J Exp Med 187, 579-586.
64. Hiwasa T, Sawada T, and Sakiyama S (1990). Cysteine proteinase inhibitors and ras gene products share the same biological activities including transforming activity toward NIH3T3 mouse fibroblasts and the differentiation-inducing activity toward PC12 rat pheochromocytoma cells. Carcinogenesis 11, 75-80.
65. Petropoulos CJ, Givol I, and Hughes SH (1996). Comparative analysis of the structure and function of the chicken c-myc and v-myc genes: v-myc is a more potent inducer of cell proliferation and apoptosis than c-myc. Oncogene 12, 2611-2621.
66. McCollum AT, Nasr P, and Estus S (2002). Calpain activates caspase-3 during UV-induced neuronal death but only calpain is necessary for death. J Neurochem 2, 1208-1220.
67. Wood DE and Newcomb EW (2000). Cleavage of Bax enhances its cell death function. Exp Cell Res 256, 375-382.
68. Mandic A, Viktorsson K, Strandberg L, Heiden T, Hansson J, Linder S, and Shoshan MC (2002). Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis. Mol Cell Biol 22, 3003-3013.
69. Atencio IA, Ramachandra M, Shabram P, and Demers GW (2000). Calpain inhibitor 1 activates p53-dependent apoptosis in tumor cell lines. Cell Growth Differ 11, 247-253.
70. Chua BT, Guo K, and Li P (2000). Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem 275, 5131-5135.
71. Porn-Ares MI, Samali A, and Orrenius S (1998). Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ 5, 1028-1033.
72. Zawaski K, Gruebele A, Kaplan D, Reddy S, Mortensen A, and Novak RF (1993). Evidence for enhanced expression of c-fos, c-jun, and the Ca(2+)-activated neutral protease in rat liver following carbon tetrachloride administration. Biochem Biophys Res Commun 197, 585-590.
73. 2+-dependent neutral proteinase of human erythrocytes. Biochem Biophys Res Commun 129, 389-395.
74. Arthur JS and Crawford C (1996). Investigation of the interaction of m-calpain with phospholipids: calpain-phospholipid interactions. Biochim Biophys Acta 1293, 201-206.
75. Small GW, Chou TY, Dang CV, and Orlowski RZ (2002). Evidence for involvement of calpain in c-Myc proteolysis in vivo. Arch Biochem Biophys 400, 151-161.
76. Averna M, De Tullio R, Salamino F, Melloni E, and Pontremoli S (1999). Phosphorylation of rat brain calpastatins by protein kinase C. FEBS Lett 450, 13-16.
77. Shiraha H, Glading A, Chou J, Jia Z, and Wells A (2002). Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain, Mol Cell Biol 22, 2716-2727.
78. Glading A, Lauffenburger DA, and Wells A (2002). Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol 12, 46-54.
79. Burridge K and Chrzanowska-Wodnicka M (1996). Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 12, 463-518.
80. Yan B, Calderwood DA, Yaspan B, and Ginsberg MH (2001). Calpain cleavage promotes talin binding to the beta 3 integrin cytoplasmic domain. J Biol Chem 276, 28164-28170.
81. Nicolas G, Fournier CM, Galand C, Malbert-Colas L, Bournier O, Kroviarski Y, Bourgeois M, Camonis JH, Dhermy D, and Grandchamp B (2002). Tyrosine phosphorylation regulates alpha II spectrin cleavage by calpain. Mol Cell Biol 22, 3527-3536.
82. Bi R, Rong Y, Bernard A, Khrestchatisky M, and Baudry M (2000). Src-mediated tyrosine phosphorylation of NR2 subunits of N-methyl-D-aspartate receptors protects from calpain-mediated truncation of their C-terminal domains. J Biol Chem 275, 26477-26483.
83. Lee CM and Reddy EP (1999). The v-myc oncogene. Oncogene 18, 2997-3003.
84. Pelengaris S, Khan M, and Evan G (2002). c-MYC: more than just a matter of life and death. Natl Rev Cancer 2, 764-776.